Outside attempts to influence the parliamentary elections in Georgia in 2020 began long before the voters went to the polls. A multi-layered disinformation campaign was accompanied by cyber-attacks.
印度疫情死亡人數破20萬 專家預測幾週內或翻倍 ntdtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ntdtv.com Daily Mail and Mail on Sunday newspapers.
Your Say
Author:
Tila Khan is DBT/Wellcome Trust India Alliance Early Career Fellow in Clinical and Public Health Research, School of Medical Science & Technology, Indian Institute of Technology-Kharagpur, Kharagpur, India.
The first reports of the novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) came in December 2019, from Wuhan, China. The disease rapidly spread across the globe, assuming pandemic proportions a little over a year ago.
1 While it was first recognized in India on 30
th January 2020, it was not until March 2020, that it became a bigger threat to the Indian public health system, forcing the government to introduce the largest lockdown covering 1.37 billion people.
Share this article
Share this article
RADNOR, Pa. and TBLISI, Georgia, April 28, 2021 /PRNewswire/ NeuroRx today announces that it has met with Dr. Ekaterine Tikaradze, Minister of Health of Georgia, and other senior leadership, to immediately initiate an Expanded Access Program (EAP) of its phase 3 drug, ZYESAMI (aviptadil acetate) for critically-ill citizens of Georgia with COVID-19 Respiratory Failure. The EAP will be conducted in collaboration with Denk Pharma Georgia, Georgia s primary pharmaceutical distributor, and under the auspices of the Potomac Institute of Policy Studies and the Richard G. Lugar Center for Public Health Research, a research facility funded by the U.S. Defense Threat Reduction Agency and named in honor of former U.S. Senator Richard G. Lugar to support international research efforts in its endeavor to stop global diseases.
Lucinda Macaringue, Quality Assurance Manager, PSI Mozambique; and
Paul Bouanchaud, Senior Research Advisor, PSI
The emerging global availability of effective COVID-19 vaccines has inspired a great deal of excitement. In Mozambique, vaccination of health workers began in March, and the country expects to have received more than 2 million doses by May. But the work to protect populations from COVID-19 doesn’t end with the development and delivery of clinically effective vaccines. A vaccine will only protect a population if enough people are willing to get it and vaccine hesitancy poses a serious threat to achieving population-level protection against COVID-19.
At PSI, we’re conducting rapid research to understand vaccine hesitancy and to incorporate consumer voices into vaccine communication and distribution strategies.